Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy

<p>Abstract</p> <p>Autologous stem cell transplantation (ASCT) is the gold standard therapy for suitable multiple myeloma (MM) patients after induction with high dose therapy. To date, the evidence of a reliable marker of prognosis in these cases remains scarce. Our aim was to eval...

Full description

Bibliographic Details
Main Authors: Guimarães Cristina, Bergantim Rui, Ramalho Renata, Couto Nuno, Guimarães João T, Trigo Fernanda
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Journal of Hematology & Oncology
Subjects:
Online Access:http://www.jhoonline.org/content/5/1/33
Description
Summary:<p>Abstract</p> <p>Autologous stem cell transplantation (ASCT) is the gold standard therapy for suitable multiple myeloma (MM) patients after induction with high dose therapy. To date, the evidence of a reliable marker of prognosis in these cases remains scarce. Our aim was to evaluate appearance of unrelated atypical serum immunofixation patterns (ASIPs) as a marker of prognosis in MM patients submitted to ASCT. We retrospectively analysed data from 65 patients. Interestingly, we observed that presence of ASIPs was associated with longer progression-free survival and longer overall survival. Our results suggested that presence of ASIPs could be a novel marker of good prognosis in MM patients submitted to ASCT.</p>
ISSN:1756-8722